Keros Therapeutics (KROS) Other Working Capital Changes (2019 - 2025)
Keros Therapeutics posted quarterly Other Working Capital Changes of -$4.2 million for Q4 2025, down 139.07% year-on-year from $10.7 million in Q4 2024, and down 441.95% on a QoQ basis from -$770000.0 in Q3 2025.
Keros Therapeutics (KROS) has 7 years of Other Working Capital Changes data on file, last reported at -$4.2 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 139.07% year-over-year to -$4.2 million; the trailing twelve-month figure through Dec 2025 stood at -$4.0 million (down 139.33% YoY), and the FY2025 full-year result was -$4.0 million, down 139.33% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$4.2 million, down from -$770000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $10.7 million in Q4 2024 and bottomed at -$9.3 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$491000.0 (2024), against an average of $434263.2.
- The widest annual swing landed in 2022, when Other Working Capital Changes tumbled 1188.89%; it then surged 656.86% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at $46000.0 in 2021, then tumbled by 3934.78% to -$1.8 million in 2022, then plunged by 429.76% to -$9.3 million in 2023, then jumped by 214.31% to $10.7 million in 2024, then sank by 139.07% to -$4.2 million in 2025.
- The last three Other Working Capital Changes figures came in at -$4.2 million (Q4 2025), -$770000.0 (Q3 2025), and -$2.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.17 Mn |
| Dec 31, 2025 | -4.17 Mn |
| Sep 30, 2025 | -770,000.00 |
| Sep 30, 2025 | -770,000.00 |
| Jun 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Dec 31, 2024 | 10.68 Mn |
| Dec 31, 2024 | 10.68 Mn |
| Sep 30, 2024 | -491,000.00 |
| Sep 30, 2024 | -491,000.00 |
| Jun 30, 2024 | -4.45 Mn |
| Jun 30, 2024 | -4.45 Mn |
| Mar 31, 2024 | 4.48 Mn |
| Mar 31, 2024 | 4.48 Mn |
| Dec 31, 2023 | -9.35 Mn |
| Dec 31, 2023 | -9.35 Mn |
| Sep 30, 2023 | 9.82 Mn |
| Sep 30, 2023 | 9.82 Mn |
| Jun 30, 2023 | -4.07 Mn |
| Jun 30, 2023 | -4.07 Mn |
| Mar 31, 2023 | 4.07 Mn |
| Mar 31, 2023 | 4.07 Mn |
| Sep 30, 2022 | -1.76 Mn |
| Sep 30, 2022 | -1.76 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Mar 31, 2022 | -764,000.00 |
| Mar 31, 2022 | -764,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Sep 30, 2021 | 162,000.00 |
| Sep 30, 2021 | 162,000.00 |
| Jun 30, 2021 | 863,000.00 |
| Jun 30, 2021 | 863,000.00 |
| Mar 31, 2021 | -1.07 Mn |
| Mar 31, 2021 | -1.07 Mn |
| Dec 31, 2020 | -15,000.00 |
| Dec 31, 2020 | -15,000.00 |
| Sep 30, 2020 | 141,000.00 |
| Sep 30, 2020 | 141,000.00 |
| Jun 30, 2020 | -183,000.00 |
| Jun 30, 2020 | -183,000.00 |
| Dec 31, 2019 | 1.65 Mn |
| Dec 31, 2019 | 1.65 Mn |
| Sep 30, 2019 | 3.14 Mn |
| Sep 30, 2019 | 3.14 Mn |
| Jun 30, 2019 | -2.50 Mn |
| Jun 30, 2019 | -2.50 Mn |
| Mar 31, 2019 | -2.50 Mn |
| Mar 31, 2019 | -2.50 Mn |